Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · IEX Real-Time Price · USD
564.60
+7.39 (1.33%)
Jun 21, 2024, 4:00 PM EDT - Market closed

Thermo Fisher Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1994
Net Income
5,9956,9507,7256,3753,696
Upgrade
Depreciation & Amortization
3,4063,3812,5922,3252,277
Upgrade
Share-Based Compensation
278307230196181
Upgrade
Other Operating Activities
-1,273-1,484-1,235-607-1,181
Upgrade
Operating Cash Flow
8,4069,1549,3128,2894,973
Upgrade
Operating Cash Flow Growth
-8.17%-1.70%12.34%66.68%9.47%
Upgrade
Capital Expenditures
-1,392-2,219-2,503-1,466-890
Upgrade
Acquisitions
-3,660-39-19,395-38-715
Upgrade
Other Investing Activities
-9099-34-6118
Upgrade
Investing Cash Flow
-5,142-2,159-21,932-1,510-1,487
Upgrade
Dividends Paid
-523-455-395-337-297
Upgrade
Share Issuance / Repurchase
-3,000-3,000-2,000-1,500-1,347
Upgrade
Debt Issued / Paid
-1556548,9112,750-1,400
Upgrade
Other Financing Activities
56-96546-74
Upgrade
Financing Cash Flow
-3,622-2,8106,581959-3,118
Upgrade
Exchange Rate Effect
-82-139194176-63
Upgrade
Net Cash Flow
-4404,046-5,8457,914305
Upgrade
Free Cash Flow
7,0146,9356,8096,8234,083
Upgrade
Free Cash Flow Growth
1.14%1.85%-0.21%67.11%6.47%
Upgrade
Free Cash Flow Margin
16.37%15.44%17.37%21.18%15.99%
Upgrade
Free Cash Flow Per Share
18.1717.6917.2817.2310.21
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).